1. Home
  2. ARRY vs NBTX Comparison

ARRY vs NBTX Comparison

Compare ARRY & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$6.93

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$33.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARRY
NBTX
Founded
1989
2003
Country
United States
France
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
ARRY
NBTX
Price
$6.93
$33.07
Analyst Decision
Buy
Strong Buy
Analyst Count
19
1
Target Price
$10.24
$26.00
AVG Volume (30 Days)
6.6M
39.7K
Earning Date
06-02-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
62.56
N/A
EPS
N/A
N/A
Revenue
$1,284,141,000.00
N/A
Revenue This Year
$16.03
N/A
Revenue Next Year
$7.79
$11.73
P/E Ratio
N/A
N/A
Revenue Growth
40.22
N/A
52 Week Low
$3.76
$2.99
52 Week High
$12.23
$41.89

Technical Indicators

Market Signals
Indicator
ARRY
NBTX
Relative Strength Index (RSI) 33.08 57.18
Support Level $6.47 $20.11
Resistance Level $10.02 N/A
Average True Range (ATR) 0.56 2.69
MACD -0.16 0.03
Stochastic Oscillator 7.54 47.72

Price Performance

Historical Comparison
ARRY
NBTX

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: